- Learning about medical tests
- Bilirubin
- Blood count
- Blood gases
- Bone marrow
- Brain scan
- Bronchoscopy
- CD4 cell count
- Computed tomography (CT) scan
- Creatinine clearance
- Dual-energy X-ray absorptiometry (DEXA) scan
- Endoscopy
- Genotypic resistance tests
- Karnofsky score
- Lactate
- Lipid test
- Liver function
- Lumbar puncture
- Lung function tests
- Magnetic resonance imaging (MRI)
- Nerve conduction tests
- Neuro-cognitive tests
- Papanicolaou (Pap) smear
- Phenotypic resistance tests
- Purified protein derivative (PPD) skin tests
- Serology
- Sigmoidoscopy and rectal biopsy
- Specimen culture
- Sputum tests
- Viral load
- X-ray & ultrasound
Bilirubin
When and why
Bilirubin is a compound that is produced when red blood cells are broken down. Due to its distinctive orange or yellow colour, a build-up of bilirubin in the blood can lead to jaundice (yellowing of the skin).
A bilirubin test is a type of blood test which helps measure liver function. In the context of HIV infection, it is often used to monitor for toxicity to antiretroviral therapy or to help assess liver function in people with viral hepatitis coinfection. The bilirubin test is also used in the diagnosis or monitoring of a wide range of blood and liver conditions.
Your doctor will take a blood sample drawn from your vein and send it to the lab for analysis.
Total serum bilirubin (the total amount of bilirubin in the blood) is normally less than 20 µmol/L (1.2 mg/dL).
A urine dip test can indicate elevated bilirubin, although a blood test will always be performed to establish an exact level.
How it will help
Elevated bilirubin indicates either a blockage in the way bilirubin is cleared from the blood by the liver or a massive breakdown of red blood cells. Causes may include liver disease, blood disease or drug toxicity. Some people may be genetically prone to bilirubin elevations when taking the protease inhibitor atazanavir.
In a person taking antiretroviral drugs, high bilirubin may lead to a review of drug treatment and a possible dose reduction.
latest aidsmap news
- Fluconazole shown to be more effective against cryptococcal meningitis at higher dose
- Promising early results for large-scale study of community-level HIV prevention initiative
- GNP+ launches website documenting global HIV exposure / transmission laws and prosecutions
- Widespread resistance to antiretrovirals among children in the Central African Republic
- Children starting HIV treatment in sub-Saharan Africa have a low risk of death
- Different paediatric responses to antiretroviral therapy in Uganda and the United Kingdom/Ireland may reflect differences in nutrition and access to cotrimoxazole
- Rare abacavir liver side-effects reported
- Abacavir treatment doesn't cause changes in biomarkers linked to heart attack, suggests small study
- Traditional healers could play key role in ART rollout
- HIV testing for mothers and children must expand, UN report shows
